APA (7th ed.) Citation

S, V., V, B., S, G., F, B., M, M., M, G., . . . S, C. (2018). Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells. Oncotarget, 9(34), 23543. https://doi.org/10.18632/oncotarget.25261

Chicago Style (17th ed.) Citation

S, Volinia, et al. "Levels of MiR-126 and MiR-218 Are Elevated in Ductal Carcinoma in Situ (DCIS) and Inhibit Malignant Potential of DCIS Derived Cells." Oncotarget 9, no. 34 (2018): 23543. https://doi.org/10.18632/oncotarget.25261.

MLA (9th ed.) Citation

S, Volinia, et al. "Levels of MiR-126 and MiR-218 Are Elevated in Ductal Carcinoma in Situ (DCIS) and Inhibit Malignant Potential of DCIS Derived Cells." Oncotarget, vol. 9, no. 34, 2018, p. 23543, https://doi.org/10.18632/oncotarget.25261.